Lindsay Tom
Physician Assistant · Reston, VANPI 1053826008
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (39.2%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Johnson & Johnson at 48.3% of the total. 2025 is the largest year on record at $36,081, 7.0 times the $5,166 reported in 2021. Among physician assistant clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,203 payments — averaging $59.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$34K
- AbbVie$9K
- UCB, Inc.$7K
- Novartis$6K
- Amgen$4K
- Mallinckrodt Hospital Products Inc.$2K
- plus $8K from 30 others
What the payments were for
- Consulting fees$12,26117%
- Speaking & faculty fees$24,35834%
- Travel & lodging$6,3409%
- Food & beverage$27,84539%
- Education$2850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(3 entities) | 156 | $34,313 |
| AbbVie | 193 | $8,776 |
| UCB, Inc. | 163 | $7,428 |
| Novartis | 96 | $5,942 |
| Amgen(2 entities) | 192 | $4,453 |
| Mallinckrodt Hospital Products Inc. | 53 | $2,111 |
| E.r. Squibb & Sons, L.L.C. | 25 | $1,166 |
| Lilly USA, LLC | 47 | $1,070 |
| AstraZeneca(2 entities) | 38 | $901 |
| Radius Health, Inc. | 58 | $831 |
| GSK | 35 | $727 |
| Aurinia Pharma U.S., Inc. | 10 | $601 |
| ANI Pharmaceuticals, Inc. | 41 | $482 |
| Pfizer | 27 | $394 |
| Sanofi | 11 | $316 |
| Janssen Scientific Affairs, LLC | 3 | $276 |
| Sandoz | 7 | $260 |
| Idorsia Pharmaceuticals US Inc | 6 | $190 |
| Boehringer Ingelheim | 6 | $127 |
| Organon | 5 | $100 |
| Fresenius Kabi USA, LLC | 3 | $91 |
| Kyowa Kirin, Inc. | 3 | $66 |
| Genentech USA, Inc. | 4 | $64 |
| Hikma Pharmaceuticals USA | 4 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Eisai Inc. | 3 | $52 |
| Ultragenyx Pharmaceutical Inc. | 2 | $47 |
| CSL Behring | 2 | $39 |
| Cumberland Pharmaceuticals, Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Pacira Therapeutics, Inc. | 1 | $22 |
| Biocon Biologics Inc | 1 | $21 |
| Invivyd Inc | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Octapharma USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$71,088 in reported general payments places this provider in the 95th percentile of 3,376 physician assistant providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Orencia ClickjectAbatacept | 23 | $248,281 |
| Humira(Cf) PenAdalimumab | 12 | $217,940 |
| Enbrel SureclickEtanercept | 14 | $146,792 |
| Taltz AutoinjectorIxekizumab | 21 | $142,945 |
| SimponiGolimumab | 13 | $139,235 |
| TymlosAbaloparatide | 17 | $63,574 |
| MethotrexateMethotrexate Sodium | 189 | $4,635 |
| Hydroxychloroquine Sulfate | 143 | $4,110 |
| Colchicine | 24 | $2,993 |
| Mycophenolate Mofetil | 25 | $2,992 |
| Gabapentin | 207 | $2,540 |
| Duloxetine Hcl | 115 | $2,443 |
| Pregabalin | 98 | $2,135 |
| Prednisone | 340 | $2,055 |
| Cevimeline Hcl | 18 | $1,915 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonSimponi | $34,313 | $139,23513 claims |
| Radius Health, Inc.Tymlos | $831 | $63,57417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,376 physician assistant providers in Virginia.
Other physician assistant in Reston
- Jennifer KallioReston$27K
- Kelly MitchellReston$17K
- Deborah NelsonReston$13K
- John DalessandroSalem$160K
- Jalal AlghabraFredericksburg$119K
- Jamie GiovanelliVirginia Beach$118K
- John CarterStaunton$90K
- Melissa AlcoxNorfolk$73K
- Robert HigginsonRichmond$66K
- Jameka McElroy-BrooklynArlington$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.